3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Fallopian Tube Neoplasms
6
Carcinoma, Ovarian Epithelial
5
Ovarian Neoplasms
3
Neoplasms
2
Triple Negative Breast Neoplasms
1
Endometrial Neoplasms
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
×
mirvetuximab soravtansine
×
Clear all
No trials found.